Crossvault Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$13.6M Sell
88,555
-4,288
-5% -$657K 5.34% 3
2022
Q1
$15.1M Buy
92,843
+380
+0.4% +$61.6K 4.85% 3
2021
Q4
$12.5M Buy
92,463
+2,798
+3% +$379K 3.76% 7
2021
Q3
$9.67M Buy
89,665
+14,175
+19% +$1.53M 3.04% 11
2021
Q2
$8.78M Buy
75,490
+4,628
+7% +$538K 2.68% 16
2021
Q1
$7.67M Buy
70,862
+675
+1% +$73.1K 2.73% 17
2020
Q4
$7.52M Buy
70,187
+3,192
+5% +$342K 2.8% 16
2020
Q3
$5.87M Buy
66,995
+3,743
+6% +$328K 2.55% 15
2020
Q2
$6.21M Buy
63,252
+5,655
+10% +$555K 2.88% 13
2020
Q1
$4.39M Buy
57,597
+18,705
+48% +$1.43M 2.46% 17
2019
Q4
$3.44M Buy
38,892
+23,260
+149% +$2.06M 1.51% 25
2019
Q3
$1.18M Hold
15,632
0.56% 36
2019
Q2
$1.14M Hold
15,632
0.56% 36
2019
Q1
$1.26M Hold
15,632
0.65% 35
2018
Q4
$1.44M Buy
15,632
+5,200
+50% +$479K 0.82% 33
2018
Q3
$987K Hold
10,432
0.51% 37
2018
Q2
$967K Hold
10,432
0.52% 34
2018
Q1
$987K Sell
10,432
-950
-8% -$89.9K 0.56% 35
2017
Q4
$1.1M Hold
11,382
0.58% 38
2017
Q3
$1.01M Hold
11,382
0.58% 38
2017
Q2
$825K Hold
11,382
0.5% 41
2017
Q1
$742K Sell
11,382
-323
-3% -$21.1K 0.46% 43
2016
Q4
$733K Sell
11,705
-1,850
-14% -$116K 0.49% 42
2016
Q3
$855K Hold
13,555
0.6% 40
2016
Q2
$839K Sell
13,555
-65,956
-83% -$4.08M 0.59% 38
2016
Q1
$4.54M Sell
79,511
-1,250
-2% -$71.4K 3.35% 9
2015
Q4
$4.78M Sell
80,761
-23
-0% -$1.36K 3.4% 7
2015
Q3
$4.4M Buy
80,784
+13,694
+20% +$745K 3.44% 8
2015
Q2
$4.51M Buy
67,090
+1,691
+3% +$114K 3.61% 5
2015
Q1
$3.83M Buy
65,399
+4,827
+8% +$283K 3.06% 12
2014
Q4
$3.96M Buy
60,572
+150
+0.2% +$9.82K 3.47% 7
2014
Q3
$3.49M Buy
60,422
+2,050
+4% +$118K 3.29% 14
2014
Q2
$3.3M Buy
58,372
+375
+0.6% +$21.2K 3.07% 15
2014
Q1
$2.98M Buy
57,997
+1,800
+3% +$92.5K 2.89% 16
2013
Q4
$2.97M Buy
+56,197
New +$2.97M 2.87% 16